S55 Genomics of Nuclear Receptor and Coregulator Action

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 4:45 PM-6:15 PM
Room 160 (BCEC)
Inez Rogatsky, PhD, Weill Medical College of Cornell University/Hospital For Special Surgery, New York, NY

Nothing to Disclose: IR
4:45 PM
Myles Brown, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Disclosure Not Provided: MB
5:15 PM
Benita S Katzenellenbogen, PhD, Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL
Nothing to Disclose: BSK
5:45 PM
Diana A Stavreva, PhD, Laboratory of Receptor Biology and Gene Expression, National Cancer Institute/NIH, Bethesda, MD
Nothing to Disclose: DAS
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire